1. Blog

HDL cholesterol: why "good" is only part of the story

HDL cholesterol is often called the "good" cholesterol. In large population studies, low HDL goes with higher heart risk . But raising HDL with drugs has not reduced heart attacks in major trials , and very high HDL is linked to higher mortality in…

7 min de lectura

En este artículo
  1. What HDL actually is
  2. Where the "good" label comes from
  3. Where the label breaks down
  4. How HDL is used today
  5. Reading your HDL result in context
  6. Measuring HDL at Santé Labs
  7. FAQ

HDL cholesterol is often called the "good" cholesterol. In large population studies, low HDL goes with higher heart risk [1]. But raising HDL with drugs has not reduced heart attacks in major trials [3][4], and very high HDL is linked to higher mortality in some cohorts [5]. HDL is a risk marker, not a target to chase.

Key takeaways

  • Low HDL cholesterol is associated with higher coronary risk in large pooled studies [1].
  • Genetic studies and drug trials suggest that raising HDL by itself does not lower heart attack risk [2][3][4].
  • In two large Danish cohorts, extremely high HDL was linked to higher all-cause mortality [5].
  • European guidelines focus treatment on LDL cholesterol, and use HDL mainly to estimate overall risk [6].
  • Reference ranges differ by lab, sex and age. Discuss your result with your doctor.

What HDL actually is

Cholesterol does not float freely in blood. It travels inside particles called lipoproteins. HDL stands for high-density lipoprotein.

A standard blood test does not count HDL particles. It measures the cholesterol carried inside them. That number is reported as HDL cholesterol, or HDL-C.

HDL particles help move cholesterol from tissues back to the liver. This is why researchers once assumed that more HDL always meant more protection. The label "good cholesterol" grew from that idea.

Where the "good" label comes from

The label rests on solid observational data. The Emerging Risk Factors Collaboration pooled data from 302,430 people in 68 prospective studies [1].

Higher HDL cholesterol was linked to lower coronary heart disease risk. The adjusted hazard ratio was 0.78 per standard deviation increase in HDL [1]. For ischaemic stroke, the link was weaker and not statistically significant [1].

So, across a population, people with higher HDL tend to have fewer heart attacks. That part of the story is real.

Where the label breaks down

Raising HDL with drugs did not prevent heart attacks

If HDL itself protected the heart, raising it should help. Two large trials tested this with niacin, a drug that raises HDL.

AIM-HIGH enrolled 3,414 people with heart disease and low HDL who were already on statins [3]. Adding niacin did not reduce the primary outcome, and the trial was stopped early for lack of benefit [3].

HPS2-THRIVE enrolled 25,673 high-risk adults [4]. Niacin with laropiprant did not significantly reduce major vascular events. It did increase serious adverse events [4].

Genes that raise HDL did not lower risk

Mendelian randomisation uses inherited gene variants as a natural experiment. Voight and colleagues studied a variant that raises HDL cholesterol on its own [2].

People carrying it had higher HDL, but no lower risk of heart attack [2]. The authors concluded that raising HDL cholesterol may not by itself lower heart attack risk [2].

Very high HDL is not always better

In the Copenhagen City Heart Study and the Copenhagen General Population Study, researchers followed 52,268 men and 64,240 women [5].

The link between HDL and all-cause mortality was U-shaped. Both very low and very high values went with higher mortality [5]. The lowest mortality was seen at 1.9 mmol/L (73 mg/dL) in men and 2.4 mmol/L (93 mg/dL) in women [5].

These are observational findings. The authors say they need confirmation in other studies [5].

How HDL is used today

The 2019 ESC/EAS guidelines on dyslipidaemias set treatment goals for LDL cholesterol [6]. HDL cholesterol is used as one input in the SCORE system, which estimates 10-year cardiovascular risk [6].

HDL also appears in the definition of metabolic syndrome. A joint statement from several international bodies counts reduced HDL as one of five criteria [7]. A diagnosis needs three of the five [7].

Commonly cited HDL thresholds

Context Threshold Source Caveats
Metabolic syndrome criterion, men HDL below 40 mg/dL (1.0 mmol/L) Joint interim statement 2009 [7] One of five criteria. Not a diagnosis on its own.
Metabolic syndrome criterion, women HDL below 50 mg/dL (1.3 mmol/L) Joint interim statement 2009 [7] One of five criteria. Not a diagnosis on its own.
Lowest all-cause mortality, men About 1.9 mmol/L (73 mg/dL) Copenhagen cohorts [5] Observational, Danish population. Not a target.
Lowest all-cause mortality, women About 2.4 mmol/L (93 mg/dL) Copenhagen cohorts [5] Observational, Danish population. Not a target.
Higher mortality, men 3.0 mmol/L (116 mg/dL) or above Copenhagen cohorts [5] Rare finding. Needs confirmation.
Higher mortality, women 3.5 mmol/L (135 mg/dL) or above Copenhagen cohorts [5] Rare finding. Needs confirmation.

Your lab report will show its own reference range. Ranges vary between labs, methods, sex and age. Do not compare your number with one range found online.

Reading your HDL result in context

HDL makes most sense next to the rest of your lipid panel. LDL cholesterol, total cholesterol and triglycerides add context. The ERFC analysis found non-HDL cholesterol strongly linked to coronary risk [1].

A single HDL value is a snapshot. It can change with many factors, including some medicines. If your result is very low or very high, the useful next step is a conversation with your doctor about your overall risk.

Measuring HDL at Santé Labs

You can book HDL cholesterol today in Barcelona as part of the Glycaemic Control Profile. It includes glucose, HbA1c, total cholesterol, HDL, LDL, triglycerides, creatinine and estimated glomerular filtration rate (eGFR).

We explain what each number means. We do not diagnose or treat, so please review your results with your doctor.

The Standard Lipid Profile is coming soon and cannot be booked yet. It will add the atherogenic index to total cholesterol, HDL, LDL and triglycerides. It does not include ApoB or Lp(a).

FAQ

Is high HDL always good?

Not always. Higher HDL is linked to lower coronary risk across populations [1]. But extremely high HDL was linked to higher all-cause mortality in two Danish cohorts [5]. Ask your doctor what your value means for you.

Should I try to raise my HDL?

Drug trials that raised HDL did not cut heart attacks [3][4]. Guidelines focus treatment goals on LDL cholesterol [6]. Any change to your lifestyle or medicines should be discussed with your doctor.

What counts as low HDL?

It depends on the lab and the context. For metabolic syndrome, the joint statement uses below 40 mg/dL in men and below 50 mg/dL in women [7]. Check the range on your own report.

Do I need to fast for an HDL test?

The ERFC analysis found that lipid risk associations were at least as strong in people who had not fasted [1]. Your lab or doctor may still ask you to fast, for example when glucose is measured in the same draw. Follow their instructions.

Why is HDL in a glycaemic control profile?

Blood sugar and blood lipids are often reviewed together. Reduced HDL and raised glucose are both criteria for metabolic syndrome [7]. Your doctor can interpret them side by side.

Can Santé Labs tell me if I need treatment?

No. We measure and explain lab tests. Decisions about diagnosis or treatment belong to your doctor.

References

  1. Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009;302(18):1993-2000 – https://pubmed.ncbi.nlm.nih.gov/19903920/
  2. Voight BF et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012;380(9841):572-580 – https://pubmed.ncbi.nlm.nih.gov/22607825/
  3. AIM-HIGH Investigators. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 2011;365:2255-2267 – https://pubmed.ncbi.nlm.nih.gov/22085343/
  4. HPS2-THRIVE Collaborative Group. Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med 2014;371:203-212 – https://pubmed.ncbi.nlm.nih.gov/25014686/
  5. Madsen CM, Varbo A, Nordestgaard BG. Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. Eur Heart J 2017;38(32):2478-2486 – https://pubmed.ncbi.nlm.nih.gov/28419274/
  6. Mach F et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020;41(1):111-188 – https://pubmed.ncbi.nlm.nih.gov/31504418/
  7. Alberti KGMM et al. Harmonizing the metabolic syndrome: a joint interim statement. Circulation 2009;120(16):1640-1645 – https://pubmed.ncbi.nlm.nih.gov/19805654/
Compartir

Plan Superhuman

Mide tu ApoB.Y más de 100 biomarcadores en total.

Una analítica completa al año en el laboratorio y un plan de acción claro.

495 € al año, con renovación anual. Cancela la renovación desde la app. Si tu médico no aprueba la solicitud, te devolvemos todo lo pagado. La lista exacta depende de tu sexo y tu edad.

Sigue leyendo

Artículos relacionados.Para leer junto a este.

Ver el blog
Ver el blog